Paper6983387
Cultures of purified human natural killer cells: growth in the presence of interleukin 2.
Timonen T and 5 others. Cell Immunol, 1982. Cited by 103 papers, by iCite.
Cite this record
ConductScience Library. Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Papers, record 6983387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6983387
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cultures of purified human natural killer cells: growth in the presence of interleukin 2.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-2 | Major topic |
| Killer Cells, Natural | Major topic |
| T-Lymphocytes | Major topic |
| Cell Division | |
| Cells, Cultured | |
| Cytotoxicity, Immunologic | |
| Humans | |
| Lymphocyte Activation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R01 CA 23809-1 | NCI NIH HHS | United States | R01CA238091 | PubMed | NIH RePORTER |
| R01CA023809 | NIH | NIH RePORTER |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24941370 | Natural killer activity: early days, advances, and seminal observations. | Crit Rev Oncog | 2014 | https://conductscience.org/library/papers/24941370 | PubMed |
| 17485522 | Interleukin-12: a master regulator. | J Exp Med | 2007 | https://conductscience.org/library/papers/17485522 | PubMed |
| 6386143 | Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines. | Cancer Metastasis Rev | 1984 | https://conductscience.org/library/papers/6386143 | PubMed |
| 6375859 | Natural killer cells: artifact to reality: an odyssey in biology. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6375859 | PubMed |
| 3955881 | Lectin-dependent cell-mediated cytotoxicity and blastogenesis by large granular-enriched and depleted lymphocytes. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3955881 | PubMed |
| 3921231 | Production of multiple cytokines by clones of human large granular lymphocytes. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3921231 | PubMed |
| 3496152 | Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3496152 | PubMed |
| 3485653 | Suppression of natural killer-cell function in humans following thermal and traumatic injury. | J Clin Immunol | 1986 | https://conductscience.org/library/papers/3485653 | PubMed |
| 3085094 | Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3085094 | PubMed |
| 3023432 | Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populations. | J Clin Immunol | 1986 | https://conductscience.org/library/papers/3023432 | PubMed |
| 3013922 | Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. | J Clin Immunol | 1986 | https://conductscience.org/library/papers/3013922 | PubMed |
| 2982734 | Transferrin receptor expression by stimulated cells in mixed lymphocyte culture. | Immunology | 1985 | https://conductscience.org/library/papers/2982734 | PubMed |
| 2497980 | Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2497980 | PubMed |
| 1697563 | Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes. | Immunology | 1990 | https://conductscience.org/library/papers/1697563 | PubMed |
| 1623902 | In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1623902 | PubMed |
| 1373350 | Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2. | Clin Exp Immunol | 1992 | https://conductscience.org/library/papers/1373350 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6983387
GET https://conductscience.org/api/papers/v1/6983387/authors